查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1526381

全球臉部注射劑市場、佔有率、規模、趨勢、行業分析報告：依產品、應用、最終用途、地區的資訊 -2024年至2032年的市場預測

Global Facial Injectable Market Share, Size, Trends, Industry Analysis Report: Information By Product, By Application, By End-Use, And By Region - Market Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到2032年，全球臉部注射劑市場預計將達到 336.3億美元。本報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

隨著經濟高效的手術的引進顯著擴大了市場需求，對臉部注射劑的需求迅速增加。這些產品為尋求美感提升且無需高成本的消費者提供了一種方便的選擇，增加了客戶群和整體市場滲透率。

此外，為了確保安全性和有效性，監管部門批准的增加推動了臉部注射劑需求的不斷成長，這使得治療更容易獲得並吸引更廣泛的消費者。例如，2023年5月，AbbVie宣布FDA批准Juvederm的Skinvibe用於改善臉頰皮膚的光滑度。這項批准突顯了臉部注射劑的接受度和創新不斷成長，推動了市場成長並增強了消費者對治療的信心。

此外，包括臉部注射在內的整容手術總數持續穩定增加，導致市場收入增加。例如，根據美國整形外科醫師協會（ASPS）的資料，2022年美國進行了2,620萬例外科和微創整容手術，比2019年增加了19%。醫療技術的進步和注射安全性的提高推動了外科和微創美容手術的成長趨勢。這些因素的結合產生協同效應並刺激臉部注射劑市場的需求。

臉部注射市場報告亮點

透明質酸（HA）細分市場在2023年佔據最大的市場佔有率，因為它廣泛用於有效的美容。

受消費者對豐唇、先進技術和多樣化產品選擇的需求的推動，預計豐唇手術將在預測期內成長最快。

由於非侵入性治療和產品創新，北美的整容手術顯著成長，並在2023年成為全球面部注射市場的主導地區。

目錄

第1章 簡介

第2章 執行摘要

第3章 研究方法

第4章 全球臉部注射市場洞察

  • 使用情況快照
  • 臉部注射市場動態
    • 推動因素和機會
    • 抑制因素和挑戰
  • PESTEL 分析
  • 臉部注射市場的應用趨勢
  • 價值鏈分析
  • 新冠肺炎（COVID-19）影響分析

第5章 全球臉部注射劑市場：依產品

  • 主要發現
  • 簡介
  • 膠原蛋白/PMMA微球
  • A型肉毒桿菌毒素
  • 玻尿酸（HA）
  • 羥基磷灰石鈣（CaHA）
  • 聚左旋乳酸（PLLA）
  • 其他

第6章 全球臉部注射劑市場：依最終用途分類

  • 主要發現
  • 簡介
  • 醫療水療中心
  • 皮膚科診所
  • 醫院

第7章 全球臉部注射市場：依應用分類

  • 主要發現
  • 簡介
  • 臉部線條修正
  • 豐唇術
  • 臉部拉皮
  • 痤瘡疤痕治療
  • 脂肪萎縮的治療
  • 其他

第8章 全球臉部注射劑市場：依地區

  • 主要發現
  • 簡介
    • 臉部注射市場評估：依地區，2019-2032年
  • 北美
    • 北美：依產品，2019-2032年
    • 北美：依應用，2019-2032年
    • 北美：依最終用途，2019-2032年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依產品，2019-2032年
    • 歐洲：依應用，2019-2032年
    • 歐洲：依最終用途，2019-2032年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 歐洲其他地區
  • 亞太地區
    • 亞太地區：依產品，2019-2032年
    • 亞太地區：依應用，2019-2032年
    • 亞太地區：依最終用途，2019-2032年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 亞太地區其他地區
  • 中東、非洲
    • 中東與非洲：依產品，2019-2032年
    • 中東與非洲：依應用，2019-2032年
    • 中東和非洲：依最終用途，2019-2032年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東、非洲
  • 拉丁美洲
    • 拉丁美洲：依產品，2019-2032年
    • 拉丁美洲：依應用，2019-2032年
    • 拉丁美洲：依最終用途，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區

第9章 競爭態勢

  • 擴張與收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/出版物

第10章 公司簡介

  • Allergan Aesthetics（AbbVie Inc.）
  • BIOPLUS CO., LTD.
  • Bioxis Pharmaceuticals
  • GALDERMA
  • Ipsen Pharma
  • Merz Pharma
  • Medytox
  • Prollenium Medical Technologies
  • SINCLAIR PLASTIC SURGERY
  • Teoxane
Product Code: PM1307

The global facial injectable market size is expected to reach USD 33.63 billion by 2032, according to a new study by Polaris Market Research. The report "Global Facial Injectable Market Share, Size, Trends, Industry Analysis Report: Information By Product, By Application, By End-Use (MedSpa, Dermatology Clinics, Hospitals), And By Region (North America, Europe, Asia-Pacific, Middle East & Africa, And Latin America) - Market Forecast, 2024 - 2032." gives a detailed insight into current market dynamics and provides analysis on future market growth.

The demand for facial injectables is rapidly increasing due to the introduction of cost-effective procedures that have significantly expanded the market's demand. Products offer accessible options for consumers seeking aesthetic enhancements without high costs, thus widening the customer base and increasing overall market penetration.

Moreover, the growing demand for facial injectables is driven by increased regulatory approvals, that ensures safety, effectiveness and make treatments more accessible and appealing to a broader range of consumers. For instance, in May 2023, AbbVie announced the FDA approval of Juvederm's Skinvive to improve skin smoothness in the cheeks. This approval emphasizes the growing acceptance and innovation in facial injectables, driving market growth and enhancing consumer confidence in treatments.

Furthermore, the overall number of cosmetic procedures, including facial injectables, continues to rise steadily, in turn driving the market revenue. For instance, according to the American Society of Plastic Surgeons (ASPS), in 2022, the United States witnessed 26.2 million surgical and minimally invasive cosmetic procedures, observing a 19% increase since 2019. This rising trends for surgical and minimally invasive cosmetic procedures are driven by advancements in medical technology and improved safety profiles of injectable products. The combination of these factors creates a synergistic effect, boosting demand within the facial injectables market.

Facial Injectable Market Report Highlights

The hyaluronic acid (HA) segment held the largest market share in 2023 due to its widespread adoption for effective cosmetic enhancements.

The lip augmentation is expected to grow fastest over the forecast period, driven by consumer demand for fuller lips, advanced techniques, and diverse product options.

North America was the dominant region in the global facial injectables market in 2023, experiencing significant growth in cosmetic procedures due to non-invasive treatments and product innovations.

The global key market players include Allergan Aesthetics (AbbVie), BIOPLUS CO., LTD., Bioxis Pharmaceuticals, GALDERMA, Ipsen Pharma, Merz Pharma, Medytox, Prollenium Medical Technologies, SINCLAIR PLASTIC SURGERY, and Teoxane

Polaris Market Research has segmented the facial injectable market report based on product, application, end-use and region:

Facial Injectable, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Collagen & PMMA Microspheres
  • Botulinum Toxin Type A
  • Hyaluronic Acid (HA)
  • Calcium Hydroxylapatite (CaHA)
  • Poly-L-lactic Acid (PLLA)
  • Others

Facial Injectable, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Facial Line Correction
  • Lip Augmentation
  • Face Lift
  • Acne Scar Treatment
  • Lipoatrophy Treatment
  • Others

Facial Injectable, End-Use (Revenue - USD Billion, 2019 - 2032)

  • MedSpa
  • Dermatology Clinics
  • Hospitals

Facial Injectable, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1.Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Facial Injectable Market Insights

  • 4.1. Facial Injectable Market - Application Snapshot
  • 4.2. Facial Injectable Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. High rate of FDA approvals is a significant catalyst for facial injectables market growth
      • 4.2.1.2. Increasing adoption of facial injectables
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Adverse side effects of facial injectables
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Facial Injectable Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Facial Injectable Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Collagen & PMMA Microspheres
    • 5.3.1. Global Facial Injectable Market, by Collagen & PMMA Microspheres, by Region, 2019-2032 (USD Billion)
  • 5.4. Botulinum Toxin Type A
    • 5.4.1. Global Facial Injectable Market, by Botulinum Toxin Type A, by Region, 2019-2032 (USD Billion)
  • 5.5. Hyaluronic Acid (HA)
    • 5.5.1. Global Facial Injectable Market, by Hyaluronic Acid (HA), by Region, 2019-2032 (USD Billion)
  • 5.6. Calcium Hydroxylapatite (CaHA)
    • 5.6.1. Global Facial Injectable Market, by Calcium Hydroxylapatite (CaHA), by Region, 2019-2032 (USD Billion)
  • 5.7. Poly-L-lactic Acid (PLLA)
    • 5.7.1. Global Facial Injectable Market, by Poly-L-lactic Acid (PLLA), by Region, 2019-2032 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Facial Injectable Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Facial Injectable Market, by End-use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 6.3. MedSpa
    • 6.3.1. Global Facial Injectable Market, by MedSpa, by Region, 2019-2032 (USD Billion)
  • 6.4. Dermatology Clinics
    • 6.4.1. Global Facial Injectable Market, by Dermatology Clinics, by Region, 2019-2032 (USD Billion)
  • 6.5. Hospitals
    • 6.5.1. Global Facial Injectable Market, by Hospitals, by Region, 2019-2032 (USD Billion)

7. Global Facial Injectable Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Facial Line Correction
    • 7.3.1. Global Facial Injectable Market, by Facial Line Correction, By Region, 2019-2032 (USD Billion)
  • 7.4. Lip Augmentation
    • 7.4.1. Global Facial Injectable Market, by Lip Augmentation, By Region, 2019-2032 (USD Billion)
  • 7.5. Face Lift
    • 7.5.1. Global Facial Injectable Market, by Face Lift, By Region, 2019-2032 (USD Billion)
  • 7.6. Acne Scar Treatment
    • 7.6.1. Global Facial Injectable Market, by Acne Scar Treatment, By Region, 2019-2032 (USD Billion)
  • 7.7. Lipoatrophy Treatment
    • 7.7.1. Global Facial Injectable Market, by Lipoatrophy Treatment, By Region, 2019-2032 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Facial Injectable Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Facial Injectable Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Facial Injectable Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Facial Injectable Market - North America
    • 8.3.1. North America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.3.3. North America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.3.4. Facial Injectable Market - U.S.
      • 8.3.4.1. U.S.: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.3.5. Facial Injectable Market - Canada
      • 8.3.5.1. Canada: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 8.4. Facial Injectable Market - Europe
    • 8.4.1. Europe: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.4. Facial Injectable Market - UK
      • 8.4.4.1. UK: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.5. Facial Injectable Market - France
      • 8.4.5.1. France: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.6. Facial Injectable Market - Germany
      • 8.4.6.1. Germany: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.7. Facial Injectable Market - Italy
      • 8.4.7.1. Italy: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.8. Facial Injectable Market - Spain
      • 8.4.8.1. Spain: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.9. Facial Injectable Market - Netherlands
      • 8.4.9.1. Netherlands: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.10. Facial Injectable Market - Russia
      • 8.4.10.1. Russia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.11. Facial Injectable Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.11.2. Rest of Europe.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.11.3. Rest of Europe: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 8.5. Facial Injectable Market - Asia Pacific
    • 8.5.1. Asia Pacific: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.4. Facial Injectable Market - China
      • 8.5.4.1. China: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.5. Facial Injectable Market - India
      • 8.5.5.1. India: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.6. Facial Injectable Market - Malaysia
      • 8.5.6.1. Malaysia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.7. Facial Injectable Market - Japan
      • 8.5.7.1. Japan: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.8. Facial Injectable Market - Indonesia
      • 8.5.8.1. Indonesia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.9. Facial Injectable Market - South Korea
      • 8.5.9.1. South Korea: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.10. Facial Injectable Market - Australia
      • 8.5.10.1. Australia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.10.2. Australia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.10.3. Australia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.11. Facial Injectable Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 8.6. Facial Injectable Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.4. Facial Injectable Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.5. Facial Injectable Market - UAE
      • 8.6.5.1. UAE: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.6. Facial Injectable Market - Israel
      • 8.6.6.1. Israel: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.7. Facial Injectable Market - South Africa
      • 8.6.7.1. South Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.8. Facial Injectable Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 8.7. Facial Injectable Market - Latin America
    • 8.7.1. Latin America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.7.4. Facial Injectable Market - Mexico
      • 8.7.4.1. Mexico: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.7.5. Facial Injectable Market - Brazil
      • 8.7.5.1. Brazil: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.7.6. Facial Injectable Market - Argentina
      • 8.7.6.1. Argentina: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.7.7. Facial Injectable Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.7.7.2. Rest of Latin America.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Allergan Aesthetics (AbbVie Inc.)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BIOPLUS CO., LTD.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bioxis Pharmaceuticals
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. GALDERMA
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Ipsen Pharma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merz Pharma
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Medytox
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Prollenium Medical Technologies
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. SINCLAIR PLASTIC SURGERY
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Teoxane
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 3 Global Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 4 Facial Injectable Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 6 North America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 7 North America: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 8 U.S.: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 9 U.S.: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 10 U.S.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Canada: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 12 Canada: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 13 Canada: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 14 Europe: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 15 Europe: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 16 Europe: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 17 UK: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 18 UK: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 19 UK: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 20 France: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 21 France: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 22 France: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Germany: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 25 Germany: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Italy: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Italy: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 28 Italy: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 29 Spain: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 30 Spain: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 31 Spain: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Russia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Russia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 37 Russia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 38 Rest of Europe: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 39 Rest of Europe: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 40 Rest of Europe: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 41 Asia Pacific: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 42 Asia Pacific: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 43 Asia Pacific: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 44 China: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 45 China: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 46 China: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 47 India: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 48 India: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 49 India: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 50 Malaysia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Malaysia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 52 Malaysia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Japan: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Japan: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 55 Japan: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 56 Indonesia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 57 Indonesia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 58 Indonesia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 59 South Korea: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 60 South Korea: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 61 South Korea: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 62 Australia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 63 Australia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 64 Australia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 65 Rest of Asia Pacific: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 66 Rest of Asia Pacific: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 67 Rest of Asia Pacific: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Middle East & Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 69 Middle East & Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 70 Middle East & Africa: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 71 Saudi Arabia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 72 Saudi Arabia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 73 Saudi Arabia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 74 UAE: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 75 UAE: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 76 UAE: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 77 Israel: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 78 Israel: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 79 Israel: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 80 South Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 81 South Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 82 South Africa: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 85 Rest of Middle East & Africa: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 86 Latin America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 87 Latin America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 88 Latin America: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 89 Mexico: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 90 Mexico: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 91 Mexico: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 92 Brazil: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 93 Brazil: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 94 Brazil: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 95 Argentina: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 96 Argentina: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 97 Argentina: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 98 Rest of Latin America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 99 Rest of Latin America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 100 Rest of Latin America: Facial Injectable Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Facial Injectable Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by End-use
  • Figure 7. Global Facial Injectable Market, by End-use, 2023 & 2032 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Facial Injectable Market, by Product, 2023 & 2032 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Facial Injectable Market, by Application, 2023 & 2032 (USD Billion)
  • Figure 12. Facial Injectable Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Facial Injectable Market